Vasotop 30mg Infusion
Marketer
Cipla Ltd
Salt Composition
Nimodipine (30mg)
Overview Vasotop 30mg Infusion
CerebroProtect 30mg Infusion is a medication administered to manage and mitigate subsequent brain injury following a subarachnoid hemorrhage (brain bleed). Classified as a calcium channel blocker, it enhances cerebral perfusion and safeguards cognitive function. Administered under strict medical guidance, dosage is individualized based on the treatment objective and disease severity. Continue the infusion as directed by your physician. Strictly adhere to your doctor's instructions throughout treatment. Commonly reported adverse effects include skin rash, headache, gastrointestinal upset, hypotension, and bradycardia. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Dizziness may occur; refrain from operating machinery or driving until the drug's effects are understood. Prior to commencing treatment, disclose any pre-existing cardiac conditions. Pregnant or lactating individuals must seek medical counsel before using this medication. Complete disclosure of all other medications, particularly those for hypertension or cardiac issues, is crucial.
Primary Ingredients of Vasotop 30mg Infusion
No text provided. Please provide the text you wish me to rephrase.
Uses of Vasotop 30mg Infusion
Bleeding into the subarachnoid space
Major Benefits of Vasotop 30mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vasotop 30mg Infusion:
- Rash
- Headache
- Stomach discomfort
- Nausea
- Decreased blood pressure
- Slow heart rate
How to use Vasotop 30mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vasotop 30mg Infusion works:
Cerebrovascular infusion Vasotop 30mg, a calcium channel antagonist, promotes cerebral vasodilation, easing blood flow and thereby mitigating post-hemorrhagic brain injury.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vasotop 30mg Infusion and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Vasotop 30mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Vasotop 30mg Infusion while breastfeeding is likely safe. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Administering Vasotop 30mg Infusion may induce drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The use of 30mg Vasotop Infusion in individuals with kidney disease appears to pose minimal risk. Current evidence indicates that dose modification may be unnecessary for this patient group. However, medical consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 30mg Vasotop infusions to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vasotop 30mg Infusion :
NA
Facts to Know About Vasotop 30mg Infusion
| Label | Value |
|---|---|
| Chemical Classification | Dihydropyridine carboxylic acid derivatives |
| Developing Habits | No. |
| Type of Treatment | Heart |
| Actions | Dihydropyridine Calcium Channel Blockers |
3,018 People bought this recently